Relationship of DNA ploidy to hormone receptor status and proliferation in invasive breast carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 126, Issue 12, 2000, Pages 707-710

  Spiethoff, Andreas ^a   Schenck, Andreas ^a   Bohrer, Manfred ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Breast carcinoma; DNA ploidy; Hormone receptor; Image cytometry; Ki 67 antigen

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; HORMONE RECEPTOR; KI 67 ANTIGEN; PROGESTERONE; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0033679241     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320000166     Document Type: Article

References (24)

1. Image cytometry of breast carcinomas that are diploid by flow cytometry: Time to revise the concepts of DNA diploidy?
2. Different risk groups in node-negative breast cancer: Prognostic value of cytophotometrically assessed DNA, morphometry and texture
3. Identification of a low-risk group of stage I breast cancer patients by cytometrically assessed DNA and nuclear texture parameters
4. Optical microscope system for standardized cell measurements and analyses
5. Quality control in image cytometry: DNA ploidy
6. Flow cytometric (DNA content and S-phase fraction) analysis of breast cancer
7. Prognostic significance of DNA ploidy in a series of 690 primary breast cancer patients
8. Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical and pathologic variables
9. Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: Results of the prospective Multicenter Morphometric Mammary Carcinoma Project
10. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma
11. Nicholson R1 (1989) Ki-67 immunostaining in primary breast cancer: Pathological and clinical associations
12. Method for grading breast cancer
13. DNA ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast
14. Breast cancer cell kinetics: Immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness
15. Correlation of flow cytometry to clinical factors, hormone receptors, and histopathological grade in stage I and II invasive breast carcinoma
16. The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients
17. DNA index, S-phase fraction, histological grade and prognosis in breast cancer
18. DNA flow cytometry in node-positive breast cancer. Prognostic value and correlation with morphologic and clinical factors
19. Prognostic factors in primary breast carcinoma
20. Ki-67, p53, Er-receptors, DNA ploidy and S-phase as prognostic factors in T1 node negative breast cancer
21. Vorschlag zur einheitlichen Definition eines Immunreaktiven Score (IRS) fur den immunhistochemischen Ostrogenrezeptor-Nachweis (ER-ICA) im Mammakarzinomgewebe
22. Flow cytometry in primary breast cancer: Improving the prognoslic value of the fraction of cells in the S-phase by optimal categorization of cut-off levels
23. DNA-Zytometrie beim Mammakarzinom. Ubersicht zur Methode und zum Stellenwert bei der Prognoseabschatzung